Skip to main content

Publications

Found 170 results
Author [ Title(Desc)] Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
3
Magee LA, von Dadelszen P, Asztalos E, Ross S, Rey E. 34 weeks of gestation-lost in translation. J Obstet Gynaecol Can. 2014;36(6):480-481.  (706.24 KB)
A
Kozic J, Benton S, Hutcheon J, Payne BA, Magee LA, von Dadelszen P. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(10):995-1004.  (280.12 KB)
Nathan H, de Greeff A, Hezelgrave NL, Chappell L, Shennan A. An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2. Blood Press Monit. 2015;20(1):52-5.  (217.35 KB)
Tsigas E. Advocacy is essential to supporting women with pre-eclampsia. Obstet Med. 2017;10(1):33-35.  (85.27 KB)
Tsigas E, Magee LA. Advocacy organisations as partners in pre-eclampsia progress: patient involvement improves outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):523-36.  (438.09 KB)
Benton S, von Dadelszen P. Are long-term health risks of pre-eclampsia and intrauterine growth restriction really the same?. BJOG. 2015;122(13):1824.  (33.63 KB)
Cormick G, Betrán A, Harbron J, Purnat T, Parker C, Hall D, et al.. Are women with history of pre-eclampsia starting a new pregnancy in good nutritional status in South Africa and Zimbabwe?. BMC Pregnancy Childbirth. 2018;18(1):236.  (712.34 KB)
Payne BA, Hutcheon J, Dunsmuir D, Cloete G, Dumont G, Hall D, et al.. Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. J Obstet Gynaecol Can. 2015;37(1):16-24.  (1.11 MB)
Payne BA, Kyle PM, Lim K, Lisonkova S, Magee LA, Pullar B, et al.. An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the fullPIERS database. Pregnancy Hypertens. 2013;3(3):166-71.  (232.97 KB)
Ukah V, Payne BA, Hutcheon J, Ansermino JM, Ganzevoort J, Thangaratinam S, et al.. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659-665.  (237.99 KB)
Payne BA, Magee LA, von Dadelszen P. Assessment, surveillance and prognosis in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):449-62.  (178.71 KB)
Katageri G, Charantimath U, Joshi A, Vidler M, Ramadurg U, Sharma S, et al.. Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India. Reproductive Health [Internet]. 2018;15(S1). https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-018-0531-6http://link.springer.com/content/pdf/10.1186/s12978-018-0531-6.pdf (460.75 KB)
Myatt L, Roberts J, Redman C. Availability of COLLECT, a database for pregnancy and placental research studies worldwide. Placenta. 2017;57:223-224.  (141.67 KB)
C
Hofmeyr J, Manyame S. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev. 2017;9:CD011192.  (116.05 KB)
Hofmeyr J, Lawrie T, Atallah Á, Duley L, Torloni M. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;(6):CD001059.  (1.4 MB)
Cormick G, Ciapponi A, Cafferata M, Belizan J. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev. 2015;(6):CD010037.  (930.69 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial. Acta Obstet Gynecol Scand. 2016;95(7):763-76.  (803.67 KB)
Magee LA, von Dadelszen P, Allen V, Ansermino JM, Audibert F, Barrett J, et al.. The Canadian Perinatal Network: a national network focused on threatened preterm birth at 22 to 28 weeks' gestation. J Obstet Gynaecol Can. 2011;33(2):111-120.  (322.85 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?. Hypertension. 2016;68(5):1153-1159.  (476.19 KB)
Magee LA, Synnes A, von Dadelszen P, Hutfield A, Chanoine J-P, Côté A-M, et al.. CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial. Pregnancy Hypertens. 2018;14:15-22.  (1011.52 KB)
CLIP Feasibility. 2016 .  (50 MB)
Roberts J, Mascalzoni D, Ness R, Poston L. Collaboration to Understand Complex Diseases: Preeclampsia and Adverse Pregnancy Outcomes. Hypertension. 2016;67(4):681-7.  (400.35 KB)
Myers J, Myatt L, Roberts J, Redman C. COLLECT, a collaborative database for pregnancy and placental research studies worldwide. BJOG. 2019;126(1):8-10.  (127.54 KB)
Boene H, Vidler M, Augusto O, Sidat M, Macete E, Menéndez C, et al.. Community health worker knowledge and management of pre-eclampsia in southern Mozambique. Reprod Health. 2016;13(Suppl 2):105.  (882.13 KB)
Ramadurg U, Vidler M, Charanthimath U, Katageri G, Bellad M, A M, et al.. Community health worker knowledge and management of pre-eclampsia in rural Karnataka State, India. Reprod Health. 2016;13(Suppl 2):113.  (629.01 KB)
Sotunsa J, Vidler M, Akeju D, Osiberu M, Orenuga E, Oladapo O, et al.. Community health workers' knowledge and practice in relation to pre-eclampsia in Ogun State, Nigeria: an essential bridge to maternal survival. Reprod Health. 2016;13(Suppl 2):108.  (287.53 KB)
Akeju D, Vidler M, Oladapo O, Sawchuck D, Qureshi R, von Dadelszen P, et al.. Community perceptions of pre-eclampsia and eclampsia in Ogun State, Nigeria: a qualitative study. Reprod Health. 2016;13 Suppl 1:57.  (838.19 KB)
Boene H, Vidler M, Sacoor C, Nhama A, Nhacolo A, Bique C, et al.. Community perceptions of pre-eclampsia and eclampsia in southern Mozambique. Reprod Health. 2016;13 Suppl 1:33.  (1.01 MB)
Vidler M, Charanthimath U, Katageri G, Ramadurg U, Karadiguddi C, Sawchuck D, et al.. Community perceptions of pre-eclampsia in rural Karnataka State, India: a qualitative study. Reprod Health. 2016;13 Suppl 1:35.  (810.48 KB)
Marianne V. Community perceptions of the hypertensive disorders of pregnancy. In 2017.  (2.63 MB)
Firoz T, Vidler M, Makanga P, Boene H, Chiaú R, Sevene E, et al.. Community perspectives on the determinants of maternal health in rural southern Mozambique: a qualitative study. Reprod Health. 2016;13(Suppl 2):112.  (1019.85 KB)
Khowaja A, Qureshi R, Sheikh S, Zaidi S, Salam R, Sawchuck D, et al.. Community's perceptions of pre-eclampsia and eclampsia in Sindh Pakistan: a qualitative study. Reprod Health. 2016;13 Suppl 1:36.  (398.75 KB)
Khowaja A, Mitton C, Qureshi R, Bryan S, Magee LA, von Dadelszen P, et al.. A comparison of maternal and newborn health services costs in Sindh Pakistan. PLoS One. 2018;13(12):e0208299.  (645.08 KB)
Chou D, Tunçalp Ö, Firoz T, Barreix M, Filippi V, von Dadelszen P, et al.. Constructing maternal morbidity - towards a standard tool to measure and monitor maternal health beyond mortality. BMC Pregnancy Childbirth. 2016;16:45.  (6.99 MB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?. BJOG. 2016;123(7):1135-41.  (144.71 KB)
Solomon C, Greene M. Control of hypertension in pregnancy--if some is good, is more worse?. N Engl J Med. 2015;372(5):475-6.  (342.05 KB)
Ahmed R, Gafni A, Hutton E, Hu Z, Pullenayegum E, von Dadelszen P, et al.. The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial). Hypertension. 2016;68(4):1049-55.  (470.91 KB)
Nathan H, Boene H, Munguambe K, Sevene E, Akeju D, Olalekan A, et al.. The CRADLE vital signs alert: qualitative evaluation of a novel device designed for use in pregnancy by healthcare workers in low-resource settings. Reprod Health. 2018;15(1):5.  (394.63 KB)
Burton G, Jauniaux E. The cytotrophoblastic shell and complications of pregnancy. Placenta. 2017;60:134-139.  (1.81 MB)
D
Akeju D, Oladapo O, Vidler M, Akinmade A, Sawchuck D, Qureshi R, et al.. Determinants of health care seeking behaviour during pregnancy in Ogun State, Nigeria. Reprod Health. 2016;13 Suppl 1:32.  (756.61 KB)
Payne BA, Groen H, Ukah V, Ansermino JM, Bhutta ZA, Grobman W, et al.. Development and internal validation of a multivariable model to predict perinatal death in pregnancy hypertension. Pregnancy Hypertens. 2015;5(4):315-21.  (505.41 KB)
Payne BA, Ryan H, Bone J, Magee LA, Aarvold A, Ansermino JM, et al.. Development and internal validation of the multivariable CIPHER (Collaborative Integrated Pregnancy High-dependency Estimate of Risk) clinical risk prediction model. Crit Care. 2018;22(1):278.  (961.71 KB)
Allotey J, Marlin N, Mol B, von Dadelszen P, Ganzevoort J, Akkermans J, et al.. Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study. Diagnostic and Prognostic Research. 2017;1(1).  (428.07 KB)
Dunsmuir D, Payne BA, Cloete G, Petersen C, Görges M, Lim J, et al.. Development of mHealth applications for pre-eclampsia triage. IEEE J Biomed Health Inform. 2014;18(6):1857-64.  (300.31 KB)
Magee LA, Helewa M, Rey E. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008;30(3 Suppl):S1-S2.  (1.73 MB)
Griffin M, Seed P, Webster L, Myers J, MacKillop L, Simpson N, et al.. Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height. Ultrasound Obstet Gynecol. 2015;46(2):182-90.  (349.22 KB)
Ukah V, Mbofana F, Rocha B, Loquiha O, Mudenyanga C, Usta M, et al.. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique. Hypertension. 2017;69(3):469-474.  (378.99 KB)
Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016;123(7):1143-51.  (153.93 KB)

Pages